Daniel Silverman

Daniel H Silverman

HS Clinical Professor, Molecular and Medical Pharmacology, University of California Los Angeles

(310) 825-4257

Medical Center, MC694215
Los Angeles, CA 90095





Member, Brain Research Institute, JCCC Cancer Molecular Imaging, Molecular Pharmacology GPB Home Area, Physics & Biology in Medicine GPB Home Area, Santa Monica Nuclear Medicine Services

Research Interests

The two major goals of our research program are 1) to explore in living human brain the interactions and neurologic bases of memory, mood, and pain perception — with respect to both normal and disordered function (as occurs in dementia, depression, and chronic pain syndromes), and 2) to develop noninvasive methodologies with which to optimize management of breast and colorectal cancers. These apparently disparate objectives are united through use of low-level radioactive biochemicals to characterize and map in the human body the distribution of processes having pressing relevance to patients seen in Nuclear and Internal Medicine. Both lines of research involve extensive application of positron emission tomography. With a focus ranging from molecular processes to human behaviors, our research activities correspondingly span the ‘bench to bedside’ spectrum from biochemical work in vitro, to monitoring and impacting upon progress of patients in the Ahmanson Biological Imaging Clinic.


Daniel H. Silverman, M.D., Ph.D., is Head of the Neuronuclear Imaging Section of the Ahmanson Translational Imaging Division at UCLA Medical Center, on the Executive Committee of the UCLA Alzheimer’s Disease Research Center, and a Professor in the Department of Molecular and Medical Pharmacology, University of California, Los Angeles. He obtained his Ph.D. in Biological Chemistry at Harvard University, and postdoctoral research training in Biochemistry and Molecular Pharmacology at Harvard Medical School. He obtained his M.D. from The Ohio State University College of Medicine, subsequently completed post-M.D. training at UCLA, and then obtained certification from both the American Board of Internal Medicine and the American Board of Nuclear Medicine.